talquetamab will raise the degree or impact of ergotamine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on. Talquetamab results in cytokine release syndrome (CRS) that may suppress action of CYP enzymes, resulting in greater publicity of CYP substrates.Keep an eye on Carefully (one)omaveloxolone will decrease t… Read More